These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

700 related items for PubMed ID: 16741965

  • 1. Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization.
    van Driel M, Koedam M, Buurman CJ, Roelse M, Weyts F, Chiba H, Uitterlinden AG, Pols HA, van Leeuwen JP.
    J Cell Biochem; 2006 Oct 15; 99(3):922-35. PubMed ID: 16741965
    [Abstract] [Full Text] [Related]

  • 2. Mineralization of three-dimensional osteoblast cultures is enhanced by the interaction of 1α,25-dihydroxyvitamin D3 and BMP2 via two specific vitamin D receptors.
    Chen J, Dosier CR, Park JH, De S, Guldberg RE, Boyan BD, Schwartz Z.
    J Tissue Eng Regen Med; 2016 Jan 15; 10(1):40-51. PubMed ID: 23784946
    [Abstract] [Full Text] [Related]

  • 3. 24R,25-dihydroxyvitamin D3 promotes the osteoblastic differentiation of human mesenchymal stem cells.
    Curtis KM, Aenlle KK, Roos BA, Howard GA.
    Mol Endocrinol; 2014 May 15; 28(5):644-58. PubMed ID: 24597546
    [Abstract] [Full Text] [Related]

  • 4. Vitamin K2 promotes 1alpha,25(OH)2 vitamin D3-induced mineralization in human periosteal osteoblasts.
    Koshihara Y, Hoshi K, Ishibashi H, Shiraki M.
    Calcif Tissue Int; 1996 Dec 15; 59(6):466-73. PubMed ID: 8939773
    [Abstract] [Full Text] [Related]

  • 5. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S, Shevde NK, Pike JW.
    J Bone Miner Res; 2005 Feb 15; 20(2):305-17. PubMed ID: 15647825
    [Abstract] [Full Text] [Related]

  • 6. Vitamin D metabolites regulate osteocalcin synthesis and proliferation of human bone cells in vitro.
    Skjødt H, Gallagher JA, Beresford JN, Couch M, Poser JW, Russell RG.
    J Endocrinol; 1985 Jun 15; 105(3):391-6. PubMed ID: 3873510
    [Abstract] [Full Text] [Related]

  • 7. 25-Dehydro-1alpha-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change.
    Bula CM, Bishop JE, Ishizuka S, Norman AW.
    Mol Endocrinol; 2000 Nov 15; 14(11):1788-96. PubMed ID: 11075812
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
    Kuno H, Kurian SM, Hendy GN, White J, deLuca HF, Evans CO, Nanes MS.
    Endocrinology; 1994 Jun 15; 134(6):2524-31. PubMed ID: 8194478
    [Abstract] [Full Text] [Related]

  • 9. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells.
    Pernalete N, Mori T, Nishii Y, Slatopolsky E, Brown AJ.
    Endocrinology; 1991 Aug 15; 129(2):778-84. PubMed ID: 1649745
    [Abstract] [Full Text] [Related]

  • 10. A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells.
    Miyahara T, Simoura T, Osahune N, Uchida Y, Sakuma T, Nemoto N, Kozakai A, Takamura T, Yamazaki R, Higuchi S, Chiba H, Iba K, Sawada N.
    Calcif Tissue Int; 2002 Jun 15; 70(6):488-95. PubMed ID: 12016462
    [Abstract] [Full Text] [Related]

  • 11. Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone.
    van Leeuwen JP, Birkenhäger JC, van den Bemd GC, Pols HA.
    Biochim Biophys Acta; 1996 Jun 05; 1312(1):54-62. PubMed ID: 8679716
    [Abstract] [Full Text] [Related]

  • 12. High dose 1,25(OH)2D3 inhibits osteoblast mineralization in vitro.
    Yamaguchi M, Weitzmann MN.
    Int J Mol Med; 2012 May 05; 29(5):934-8. PubMed ID: 22307202
    [Abstract] [Full Text] [Related]

  • 13. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts.
    Schedlich LJ, Muthukaruppan A, O'Han MK, Baxter RC.
    Mol Endocrinol; 2007 Oct 05; 21(10):2378-90. PubMed ID: 17595320
    [Abstract] [Full Text] [Related]

  • 14. C-25 hydroxylation of 1alpha,24(R)-dihydroxyvitamin D3 is catalyzed by 25-hydroxyvitamin D3-24-hydroxylase (CYP24A1): metabolism studies with human keratinocytes and rat recombinant CYP24A1.
    Astecker N, Bobrovnikova EA, Omdahl JL, Gennaro L, Vouros P, Schuster I, Uskokovic MR, Ishizuka S, Wang G, Reddy GS.
    Arch Biochem Biophys; 2004 Nov 15; 431(2):261-70. PubMed ID: 15488475
    [Abstract] [Full Text] [Related]

  • 15. Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cells.
    Inaba M, Terada M, Koyama H, Yoshida O, Ishimura E, Kawagishi T, Okuno Y, Nishizawa Y, Otani S, Morii H.
    J Bone Miner Res; 1995 Jul 15; 10(7):1050-6. PubMed ID: 7484280
    [Abstract] [Full Text] [Related]

  • 16. Activation of the human osteocalcin gene by 24R,25-dihydroxyvitamin D3 occurs through the vitamin D receptor and the vitamin D-responsive element.
    Uchida M, Ozono K, Pike JW.
    J Bone Miner Res; 1994 Dec 15; 9(12):1981-7. PubMed ID: 7872065
    [Abstract] [Full Text] [Related]

  • 17. Osteoblast differentiation and control by vitamin D and vitamin D metabolites.
    van Driel M, Pols HA, van Leeuwen JP.
    Curr Pharm Des; 2004 Dec 15; 10(21):2535-55. PubMed ID: 15320744
    [Abstract] [Full Text] [Related]

  • 18. Synergistic effect of 1α,25-dihydroxyvitamin D3 and 17β-estradiol on osteoblast differentiation of pediatric MSCs.
    Li J, Padwa BL, Zhou S, Mullokandova J, LeBoff MS, Glowacki J.
    J Steroid Biochem Mol Biol; 2018 Mar 15; 177():103-108. PubMed ID: 28765038
    [Abstract] [Full Text] [Related]

  • 19. Bone-specific transcription factor Runx2 interacts with the 1alpha,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells.
    Paredes R, Arriagada G, Cruzat F, Villagra A, Olate J, Zaidi K, van Wijnen A, Lian JB, Stein GS, Stein JL, Montecino M.
    Mol Cell Biol; 2004 Oct 15; 24(20):8847-61. PubMed ID: 15456860
    [Abstract] [Full Text] [Related]

  • 20. 1Alpha,25-(OH)2D3 acts in the early phase of osteoblast differentiation to enhance mineralization via accelerated production of mature matrix vesicles.
    Woeckel VJ, Alves RD, Swagemakers SM, Eijken M, Chiba H, van der Eerden BC, van Leeuwen JP.
    J Cell Physiol; 2010 Nov 15; 225(2):593-600. PubMed ID: 20506116
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.